ArticleMedical physics2022
Label-free coronavirus disease 2019 lesion segmentation based on synthetic healthy lung image subtraction.
Article in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Unsupervised non-small cell lung cancer tumor segmentation using cycled generative adversarial network with similarity-based discriminator.Journal of applied clinical medical physics · 2025Article
- Synthetic Data Generation via Generative Adversarial Networks in Healthcare: A Systematic Review of Image- and Signal-Based Studies.IEEE open journal of engineering in medicine and biology · 2025Article
- Label-free coronavirus disease 2019 lesion segmentation based on synthetic healthy lung image subtraction.Medical physics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeCoronavirus disease 2019 (COVID-19) has become a global pandemic and is still posing a severe health risk to the public. Accurate and efficient segmentation of pneumonia lesions in computed tomography (CT) scans is vital for treatment decision-making. We proposed a novel unsupervised approach using a cycle consistent generative adversarial network (cycle-GAN) which automates and accelerates the process of lesion delineation.
methodThe workflow includes lung volume segmentation, healthy lung image synthesis, infected and healthy image subtraction, and binary lesion mask generation. The lung volume was first delineated using a pre-trained U-net and worked as the input for the following network. A cycle-GAN was trained to generate synthetic healthy lung CT images from infected lung images. After that, the pneumonia lesions were extracted by subtracting the synthetic healthy lung CT images from the infected lung CT images. A median filter and k-means clustering were then applied to contour the lesions. The auto segmentation approach was validated on three different datasets.
resultsThe average Dice coefficient reached 0.666 ± 0.178 on the three datasets. Especially, the dice reached 0.748 ± 0.121 and 0.730 ± 0.095, respectively, on two public datasets Coronacases and Radiopedia. Meanwhile, the average precision and sensitivity for lesion segmentation on the three datasets were 0.679 ± 0.244 and 0.756 ± 0.162. The performance is comparable to existing supervised segmentation networks and outperforms unsupervised ones.
conclusionThe proposed label-free segmentation method achieved high accuracy and efficiency in automatic COVID-19 lesion delineation. The segmentation result can serve as a baseline for further manual modification and a quality assurance tool for lesion diagnosis. Furthermore, due to its unsupervised nature, the result is not influenced by physicians' experience which otherwise is crucial for supervised methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.